SCHEMBL23177232

SCHEMBL23177232

c1ccc(-c2nc(-c3ccccc3)c(-n3c4ccccc4c4cc(-c5ccc6c(c5)c5ccccc5n6-c5ccccc5)ccc43)c(-c3ccccc3)n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
KDM4E B2RXH2 1/20 0.47
NPY5R Q15761 2/20 0.40
PTGER4 P35408 2/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
IL1R1 P14778 1/20 0.35
TSPO P30536 1/20 0.35
WHR1 P49842 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.35
ADORA1 P30542 4/20 0.34
ADORA3 P0DMS8 3/20 0.34
ADORA2A P29274 3/20 0.34
ADORA2B P29275 1/20 0.34
AVPR1A P37288 1/20 0.33
ADK P55263 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23177395 1.00 ATM (0.47) ATML3MBTL1KDM4ENPY5RPTGER4
SCHEMBL23177246 0.97 ATM (0.47) ATML3MBTL1KDM4ENPY5RPTGER4
SCHEMBL23177147 0.96 ATM (0.42) ATML3MBTL1KDM4ENPY5RPTGER4
SCHEMBL23177138 0.94 ATM (0.42) ATML3MBTL1KDM4ENPY5RPTGER4
SCHEMBL23177390 0.94 ATM (0.41) ATML3MBTL1KDM4ENPY5RPTGER4
SCHEMBL23177385 0.94 ATM (0.44) ATML3MBTL1KDM4ENPY5RPTGER4
SCHEMBL23177054 0.92 NR3C1 (0.43) ATML3MBTL1KDM4ENPY5RKMT2A
SCHEMBL23177156 0.92 ATM (0.42) ATML3MBTL1KDM4ENPY5RPTGER4
SCHEMBL23177137 0.91 ATM (0.39) ATML3MBTL1KDM4ENPY5RPTGER4
SCHEMBL23177056 0.90 NPY5R (0.38) ATML3MBTL1KDM4ENPY5RPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210098707-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE, AND COMPOUND IDEMITSU KOSAN CO.,LTD. (JP) 2021-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210098707-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE, AND COMPOUND L1CAM, ESR1, LEF1 ATM 1543/4885L3MBTL1 517/4885KDM4E 3410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.